Definitive Contract 75D30120C08427
- Not listed
- This is a $620,310.00 firm fixed-price definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Genesis Laboratories, Inc., a for-profit subchapter S corporation, to conduct a field trial of fipronil-laced oral bait. The contract, which has an ultimate completion date of August 24, 2026, is intended to support the CDC's vector-borne disease program by controlling tick populations and reducing Lyme disease incidence. Genesis Laboratories has previously conducted...
- This is a firm-fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Genesis Laboratories, Inc., a for-profit subchapter S corporation, to conduct a field trial of fipronil-laced bait to control immature Ixodes scapularis ticks in rodents. The contract has a total ceiling value of $249,940.00 and a completion date of September 23, 2024. Genesis Laboratories has previously received multiple federal contracts from the CDC for vector-borne disease research...
- Genesis Laboratories, Inc. was awarded a $570,428.55 firm fixed price definitive contract by the Department of Health and Human Services Centers for Disease Control and Prevention to provide a mineral lick to systematically control black-legged ticks and reduce Lyme disease incidence among white-tailed deer populations in Wellington, Colorado. As a subchapter S corporation, Genesis Laboratories will supply mineral licks intended to deliver fipronil-laced oral bait to white-tailed deer, in...
- The U.S. Centers for Disease Control and Prevention (CDC) awarded a $257,036.00 firm-fixed-price contract to the Connecticut Agricultural Experimental Station (CAES), a state government research entity, to conduct oral delivery of the acaricide (pesticide that kills ticks and mites) moxidectin to white-tailed deer populations. This effort aims to manage the vector tick Amblyomma americanum, which transmits pathogens. The contract, which has no set-aside designation, runs through September 27,...
- This is a $230,817.53 firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to the Connecticut Agricultural Experiment Station (CAES), a state government research entity. The contract is for the evaluation of the efficacy of fall application of synthetic versus natural acaricides (pesticides that kill ticks and mites). This contract does not have a set-aside designation. CAES, the prime contractor, has a history of receiving federal grants and...
- The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a Firm Fixed Price Purchase Order contract to Inc. T.erry L. Schulze, Phd, a for-profit S-corporation, for a Feasibility Tick Disease Management effort. The $230,000.00 contract, which has a completion date of September 10, 2022, is focused on tick habitat management, tick-borne disease management feasibility studies, and evaluations of acaricide application methods. The contract does not have...
- The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a $106,950 firm-fixed-price purchase order to Marshfield Clinic, Inc., a non-profit healthcare organization, to use electronic health records to identify and describe Lyme disease diagnoses. This contract, which does not have a set-aside designation, was awarded on September 14, 2020 with a completion date of September 30, 2021. Marshfield Clinic is a prime contractor that provides the CDC with...
- This is a $1,315,748.75 cost-plus-fixed-fee definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Banfieldbio Inc., a for-profit technology research company located in Woodinville, Washington. The contract is for research and development services related to developing novel pest management solutions and innovative technologies for pest control, with a focus on areas such as insect and tick management. The contract is not set-aside and has a period of...
- The Centers for Disease Control and Prevention awarded a $98,669.98 firm fixed price purchase order to Colorado State University under a sole source solicitation. The contract is for tick surveillance bioinformatics pipeline development to obtain a bioinformatics pipeline to support CDC's tick-borne disease surveillance efforts. Performance will take place in Fort Collins, Colorado over a three year period concluding in May 2023. No subcontractors or set aside designations were identified....
- This federal contract award was made by the Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) to Tick Box Technology Corporation, a manufacturer of goods, for the purchase of Tick Control System Master Cases - Bait Boxes. The contract, valued at $112,226.00, is a Firm Fixed Price purchase order with a completion date of June 30, 2019. The original solicitation was a pre-solicitation notice that cited the statutory authority of 10 U.S.C. 2304(c)(1)...
This is a 2020 contract awarded by the Centers for Disease Control and Prevention (CDC), part of the Department of Health and Human Services, to Genesis Laboratories, Inc., a for-profit subchapter S corporation. The $149,147 firm fixed-price contract is for products and services related to vector-borne disease research and prevention, specifically controlling tick populations and reducing Lyme disease incidence. Under this definitive contract, Genesis Laboratories will provide fipronil-laced oral bait products, conduct field trials, and supply mineral licks to control black-legged ticks and white-tailed deer populations. This award is not associated with a set-aside designation. Genesis Laboratories has received multiple prior CDC contracts for similar vector-borne disease control work.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Other Administrative Action | 0$ | 10/31/23 | |
| Not listed | Not listed | $149.1k | 6/2/20 |